Regulation of beta-cell mass by hormones and growth factors
- PMID: 11272193
- DOI: 10.2337/diabetes.50.2007.s25
Regulation of beta-cell mass by hormones and growth factors
Abstract
Substantial new information has accumulated on molecular mechanisms of pancreas development, regulation of beta-cell gene expression, and the role of growth factors in the differentiation, growth, and regeneration of beta-cells. The present review focuses on some recent studies on the mechanism of action of cytokines such as growth hormone (GH) and prolactin (PRL) in beta-cell proliferation and gene expression-in particular, the role of signal transducers and activators of transcription (STAT) proteins. The implication of the discovery of suppressors of cytokine signaling (SOCS) proteins for the interaction between stimulatory and inhibitory cytokines, including GH, PRL, leptin, and the proinflammatory cytokines interleukin-1 and interferon-gamma, in beta-cell survival is not yet clear. Recent studies indicate a role of cell adhesion molecules and the delta-like protein preadipocyte factor 1/fetal antigen 1 (Pref-1/FA-1) in cytokine-induced beta-cell growth and development. Surprisingly, glucagon-like peptide-1 (GLP-1) was recently found to stimulate not only insulin secretion but also beta-cell replication and differentiation, which may present a new perspective in treatment of type 2 diabetes. Together with the intriguing reports on positive effects of insulin on both beta-cell growth and function, a picture is emerging of an integrated network of signaling events acting in concert to control beta-cell mass adaptation to insulin demand.
Similar articles
-
Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I.Horm Res. 2006;66(3):101-10. doi: 10.1159/000093667. Epub 2006 May 30. Horm Res. 2006. PMID: 16735796
-
Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of langerhans.Endocrinology. 2004 Sep;145(9):4162-75. doi: 10.1210/en.2004-0201. Epub 2004 May 13. Endocrinology. 2004. PMID: 15142985
-
GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells.Diabetes Metab Res Rev. 2003 Mar-Apr;19(2):115-23. doi: 10.1002/dmrr.357. Diabetes Metab Res Rev. 2003. PMID: 12673779 Review.
-
Expression, biosynthesis and release of preadipocyte factor-1/ delta-like protein/fetal antigen-1 in pancreatic beta-cells: possible physiological implications.J Endocrinol. 2003 Feb;176(2):257-66. doi: 10.1677/joe.0.1760257. J Endocrinol. 2003. PMID: 12553874
-
Beta cell proliferation and growth factors.J Mol Med (Berl). 1999 Jan;77(1):62-6. doi: 10.1007/s001090050302. J Mol Med (Berl). 1999. PMID: 9930929 Review.
Cited by
-
Secondary diabetes mellitus in acromegaly.Endocrine. 2023 Jul;81(1):1-15. doi: 10.1007/s12020-023-03339-1. Epub 2023 Mar 8. Endocrine. 2023. PMID: 36882643 Free PMC article. Review.
-
The Role of Adiponectin during Pregnancy and Gestational Diabetes.Life (Basel). 2023 Jan 21;13(2):301. doi: 10.3390/life13020301. Life (Basel). 2023. PMID: 36836658 Free PMC article. Review.
-
A Clinical Update on Gestational Diabetes Mellitus.Endocr Rev. 2022 Sep 26;43(5):763-793. doi: 10.1210/endrev/bnac003. Endocr Rev. 2022. PMID: 35041752 Free PMC article.
-
Assessment of Insulin Secretion and Insulin Resistance in Human.Diabetes Metab J. 2021 Sep;45(5):641-654. doi: 10.4093/dmj.2021.0220. Epub 2021 Sep 30. Diabetes Metab J. 2021. PMID: 34610719 Free PMC article. Review.
-
Loss of growth hormone signaling in the mouse germline or in adulthood reduces islet mass and alters islet function with notable sex differences.Am J Physiol Endocrinol Metab. 2021 Jun 1;320(6):E1158-E1172. doi: 10.1152/ajpendo.00075.2020. Epub 2021 May 3. Am J Physiol Endocrinol Metab. 2021. PMID: 33938235 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical